Filing Details
- Accession Number:
- 0001415889-24-006070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-01 16:05:24
- Reporting Period:
- 2024-02-28
- Accepted Time:
- 2024-03-01 16:05:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1109354 | Bruker Corp | BRKR | Laboratory Analytical Instruments (3826) | 043110160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739999 | Falko Busse | 40 Manning Road Billerica MA 01821 | President, Biospin Group | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-28 | 12,000 | $19.82 | 44,859 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 7,097 | $22.19 | 51,956 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 4,384 | $34.02 | 56,340 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 4,641 | $41.95 | 60,981 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 13,852 | $86.06 | 47,129 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-28 | 12,770 | $84.97 | 34,359 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-28 | 1,500 | $84.48 | 32,859 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Purchase) | Disposition | 2024-02-28 | 12,000 | $0.00 | 12,000 | $19.82 |
| Common Stock | Stock Option (Right to Purchase) | Disposition | 2024-02-28 | 7,097 | $0.00 | 7,097 | $22.19 |
| Common Stock | Stock Option (Right to Purchase) | Disposition | 2024-02-28 | 4,384 | $0.00 | 4,384 | $34.02 |
| Common Stock | Stock Option (Right to Purchase) | Disposition | 2024-02-28 | 4,641 | $0.00 | 4,641 | $41.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-08-07 | No | 4 | M | Direct | |
| 0 | 2026-10-04 | No | 4 | M | Direct | |
| 0 | 2028-08-09 | No | 4 | M | Direct | |
| 0 | 2029-08-08 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.52 to $86.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.52 to $85.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.46 to $84.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
- The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
- The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
- The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
Billionaire Hedge Funds
